SYN Key Stats
PR Newswire10/10 08:55
PR Newswire09/16 10:35
PR Newswire09/12 13:23
PR Newswire09/11 06:58
PR Newswire09/10 12:04
|09/16/2014 09:00 EDT||Misc||Synthetic Biologics to Host Irritable Bowel Syndrome (Ibs) Investor Day|
|08/14/2014 08:30 EDT||Misc||Synthetic Biologics Inc. Q2 2014 Earnings Conference Call|
|08/14/2014||Earnings||Synthetic Biologics Inc. Q2 2014 Earnings Results|
|06/10/2014||Misc||Annual General Meeting for Synthetic Biologics Inc|
|05/15/2014 08:30 EDT||Misc||Synthetic Biologics Inc 1Q2014 Earning Conference Call|
|05/15/2014||Earnings||Synthetic Biologics Inc 1Q2014 Earning Result|
|03/31/2014 10:00 EDT||Misc||Synthetic Biologics Inc Q4 2013 Earnings Conference Call|
|03/31/2014||Earnings||Synthetic Biologics Inc Q4 2013 Earnings Results|
|11/14/2013 10:00 EDT||Misc||Synthetic Biologics to Report Third Quarter 2013 Financial Results Conference Call|
|11/14/2013||Earnings||Synthetic Biologics to Report Third Quarter 2013 Financial Results|
SYN Total Returns Comparison
This total returns chart shows the returns to an investor from both price appreciation and dividends (dividends are assumed to be reinvested). Synthetic Biologics is up 3.95% over the last year vs S&P 500 Total Return up 16.65%, Intrexon Corp up 6.78%, and Amicus Therapeutics up 175.9%.
Income Statement View Statement
Balance Sheet View Statement
Y-Ratings for SYN
Portfolio Strategies Featuring SYN
Did Synthetic Biologics make it into our Portfolio Strategies?
Start your YCharts membership now to find out.
- Sector: Healthcare
- Industry: Biotechnology
- Company Website: http://www.syntheticbiologics.com
- IR Website: http://www.syntheticbiologics.com/investors
- HQ Country: United States
- HQ State/Province: Maryland
- Incorporation Country: United States
- Incorporation State/Province: Nevada
- Est. Current Fiscal Quarter End: December 31, 2014
- Est. Current Fiscal Year End: December 31, 2014
- Last Fiscal Quarter End: June 30, 2014
- Last Fiscal Year End: December 31, 2013
- NAICS: Pharmaceutical Preparation Manufacturing
- NAICS Code: 325412
- NAICS Industry: Pharmaceutical and Medicine Manufacturing
- NAICS Sector: Manufacturing
Synthetic Biologics Inc is a biotechnology company focused on the development of novel anti-infective biologic and drug candidates targeting specific pathogens that cause serious infections and other diseases.
SYN Excel Add-In Codes
- Name: =YCI("SYN","name")
- Description: =YCI("SYN","description")
- Sector: =YCI("SYN","sector")
- Industry: =YCI("SYN","industry")
- Est. Current Fiscal Year End: =YCI("SYN","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.